Company Information
CIN
Status
Date of Incorporation
24 April 2002
State / ROC
Hyderabad / ROC Hyderabad
Last Balance Sheet
30 September 2010
Last Annual Meeting
30 September 2010
Paid Up Capital
8,785,900
Authorised Capital
10,000,000
Directors
Mary Elizabathe Joseph
Director/Designated Partner
over 22 years ago
over 22 years ago
Vaman Rao Mothe
Director/Designated Partner
over 23 years ago
over 23 years ago
Past Directors
Vijaya Chilappagari
Director
over 23 years ago
over 23 years ago
Sanjeeva Rao Mothe
Director
over 23 years ago
over 23 years ago
Patents
Described herein is a compound of Formula (I), which is the metformin salt of the naturally occurring endogenous biological compound, (R)-(+) α lipoic acid, pharmaceutical compositions containing the compound of Formula (I), and methods of treatment of diabetes or diabetic complications with the compound of Formula ...
Registered Trademarks
[Class : 5] Pharmaceutical Preparations, For Human Use, For Use In The Treatment Of Metabolic Diseases, Cardiovascular Problems, Asthma, Allergic Rhinitis, Arthritis, Menstrual Disorders, Various Cancers, Dermatological Diseases, Infectious Diseases, Intestinal Diseases, Neurological Diseases, Strees, Nervous Tension, Occasional Constipation, Menstrual Disorders, Sexual Diso...
Trade mark is likely to be removed due to non filing of Renewal request within prescribed time limit In case of any discripancy contact respective TM Registry.
[Class : 5] Pharmaceutical Preparations, For Human Use, For Use In The Treatment Of Metabolic Diseases, Cardiovascular Problems, Asthma, Allergic Rhinitis, Arthritis, Menstrual Disorders, Various Cancers, Dermatological Diseases, Infectious Diseases, Intestinal Diseases, Neurological Diseases, Stress, Nervous Tension, Occasional Constipation, Menstrual Disorders, Sexual Diso...
Trade mark is likely to be removed due to non filing of Renewal request within prescribed time limit In case of any discripancy contact respective TM Registry.
[Class : 5] Pharmaceutical Preparations, For Human Use, For Use In The Treatment Of Metabolic Diseases, Cardiovascular Problems, Asthma, Allergic Rhinitis, Arthritis, Menstrual Disorders, Various Cancers, Dermatological Diseases, Infectious Diseases, Intestinal Diseases, Neurological Diseases, Stress, Nervous Tension, Occasional Constipation, Menstrual Disorders, Sexual Diso...
Trade mark is likely to be removed due to non filing of Renewal request within prescribed time limit In case of any discripancy contact respective TM Registry.
View +4 more Brands for Indigene Pharmaceuticals Private Limited.
Documents
Form 32-221111.OCT
Evidence of cessation-211111.PDF
Optional Attachment 1-211111.PDF
Optional Attachment 2-211111.PDF
Optional Attachment 3-211111.PDF
FormSchV-031111 for the FY ending on-300910.OCT
Form23AC-021111 for the FY ending on-310310.OCT
Form66-021111 for the FY ending on-310310.OCT
Form23AC-291209 for the FY ending on-310309.OCT
Form66-291209 for the FY ending on-310309.OCT
FormSchV-291209 for the FY ending on-310309.OCT
Form 66-191108.OCT
Form 23AC-191108.OCT
Form 20B-191108.OCT
Form 23B-250908.PDF
Copy of intimation received-250908.PDF
Form 23B-200908.PDF
Copy of intimation received-200908.PDF
Form 23AC-231107.OCT
Form 20B-231107.OCT
Form 66-231107.OCT
Form 23B-161007.PDF
Copy of intimation received-161007.PDF
Form 66-131206.OCT
Form 23AC-131206.OCT
Form 20B-131206.OCT
Form 23B-271006.PDF
Copy of intimation received-271006.PDF
Balance Sheet 2004_2005.PDF
Annual Return 2004_2005.PDF
